<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="70462">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01854541</url>
  </required_header>
  <id_info>
    <org_study_id>VMRTP</org_study_id>
    <nct_id>NCT01854541</nct_id>
  </id_info>
  <brief_title>Visual Management for the Radiotherapy Process</brief_title>
  <acronym>VMRTP</acronym>
  <official_title>Visual Management for the Radiotherapy Process</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht Radiation Oncology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Maastro Clinic, The Netherlands</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht Radiation Oncology</source>
  <oversight_info>
    <authority>Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Visual Management for Radiotherapy Practice (VMRTP) aims to analyze, predict, visualize
      and shorten the waiting times for radiotherapy patients. The hypothesis is that this can be
      done by the introduction of models that can predict a patient being at risk for waiting too
      long as well as visual management tools that visualize the radiotherapy process.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a retrospective cohort of radiotherapy patients, time stamps of various steps in the
      radiotherapy process (diagnosis, multi-disciplinary board, referral, intake, simulation,
      treatment planning, quality control, first fraction of radiotherapy) will be collected.
      These will be combined with patient, tumor and patient-process (e.g. referring physician,
      treating physician, busy-at-the-time, referring hospital) related features. Based on these a
      predictive model will be learned that can estimate the probability at various stages of the
      process that the patient waits too long. Visual management will be developed that can
      visualize the predicted waiting time.

      Process interventions aimed at reducing waiting times will be tested prospectively.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">November 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort</study_design>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>referral and first day of radiotherapy</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Waiting time between referral and first day of radiotherapy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnosis and first day of radiotherapy</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Waiting time between diagnosis and first day of radiotherapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>multi-disciplinary board and first day of radiotherapy</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Waiting time between multi-disciplinary board and first day of radiotherapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intake and first day of radiotherapy</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Waiting time between intake and first day of radiotherapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>simulation and first day of radiotherapy</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Waiting time between simulation and first day of radiotherapy</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>Radiotherapy</arm_group_label>
    <description>All patients receiving radiotherapy</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All patients treated with radiotherapy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients receiving radiotherapy

        Exclusion Criteria:

        Patients not receiving radiotherapy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Andre Dekker</last_name>
    <phone>+31 88 44 55 666</phone>
    <email>andre.dekker@maastro.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chantal Overhof</last_name>
    <phone>+31 88 44 55 686</phone>
    <email>chantal.overhof@maastro.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>MAASTRO clinic</name>
      <address>
        <city>Maastricht</city>
        <zip>6229 ET</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andre Dekker</last_name>
      <phone>+31 88 4455666</phone>
      <email>andre.dekker@maastro.nl</email>
    </contact>
    <contact_backup>
      <last_name>Chantal Overhof</last_name>
      <phone>+31 88 44 55 686</phone>
      <email>chantal.overhof@maastro.nl</email>
    </contact_backup>
    <investigator>
      <last_name>Andre Dekker</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 6, 2014</lastchanged_date>
  <firstreceived_date>May 13, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cancer</keyword>
  <keyword>Radiotherapy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
